Department of Ambulatory Oncology Care Unit, Reims, France.
Department of Medical Oncology, Reims, France.
Oncologist. 2021 Feb;26(2):e338-e341. doi: 10.1002/onco.13578. Epub 2020 Nov 11.
The coronavirus disease 2019 (COVID-19) pandemic may have affected cancer management. We aimed to evaluate changes in every oncology care pathway essential step, from screening to treatment, during the pandemic. Monthly oncological activity differences between 2019 and 2020 (screening tests, histopathological analyzes, multidisciplinary tumor board meetings (MTBMs), diagnostic announcement procedures (DAPs), and treatments were calculated in two French areas experiencing different pandemic intensity (Reims and Colmar). COVID-19 has had a dramatic impact in terms of screening (-86% to -100%), diagnosis (-39%), and surgical treatment (-30%). This global decrease in all essential oncology care pathway steps contrasted with the relative stability of chemotherapy (-9%) and radiotherapy use (-16%). Outbreak occurred earlier and with more intensity in Colmar but had a comparable impact in both areas regarding MTMBs and DAPs. The current ONCOCARE-COV study is still in progress and with a longer follow-up to analyze postlockdown situation.
新型冠状病毒病 2019（COVID-19）大流行可能影响了癌症的管理。我们旨在评估大流行期间每个肿瘤学护理途径的基本步骤（从筛查到治疗）的变化。在法国两个经历不同大流行强度的地区（兰斯和科尔马），计算了 2019 年和 2020 年之间每月肿瘤学活动的差异（筛查测试、组织病理学分析、多学科肿瘤委员会会议（MTBM）、诊断通知程序（DAP）和治疗）。COVID-19 在筛查方面产生了巨大影响（-86%至-100%）、诊断（-39%）和手术治疗（-30%）。所有肿瘤学护理途径基本步骤的这种全面减少与化疗（-9%）和放疗使用（-16%）的相对稳定形成对比。科马尔爆发时间更早，强度更大，但在 MTBM 和 DAP 方面，两个地区的影响相当。目前的 ONCOCARE-COV 研究仍在进行中，并进行了更长时间的随访以分析封锁后的情况。
Zotero 插件